-
Wedbush Analyst Shares 4 Cannabis Stock Picks With Benzinga: Which Is The 'Best-Run'?
Wednesday, December 7, 2022 - 3:55pm | 717Companies in the cannabis sector do not have a lot of coverage from Wall Street analysts for a variety of different reasons. Yet Gerald Pascarelli of Wedbush Securities has picked up coverage on the sector, and he joined PreMarket Prep Plus on Wednesday to give his outlook on regulatory reform...
-
3 Biotech Stock Picks From This Wedbush Analyst
Wednesday, July 27, 2022 - 5:27pm | 580While the S&P 500 index peaked in January and has had a rough year, the biotech sector peaked last August. For the time being, both have found a short-term and possible long-term bottom in June. David Nierengarten, managing director covering the health care sector at Wedbush...
-
This Wedbush Analyst Talks AMC, Netflix And Other Stock Ideas In Hard-Hit Entertainment Sector
Wednesday, June 22, 2022 - 2:26pm | 494We're over two years into the coronavirus pandemic, and consumer behavior is still adjusting and the ramifications are still playing out in the financial markets. Most of the media and entertainment industry did not participate in the raging bull market in 2021 and is still struggling to...
-
AMC's Rally Off 'Top Gun: Maverick' Loses Altitude
Tuesday, May 31, 2022 - 5:06pm | 553Whether it's a short or long-term investment you're considering, getting in is much easier than getting out. The focus of this article will be exiting a shorter-term investment in AMC Entertainment Holdings Inc. (NYSE: AMC), the PreMarket Prep Plus stock of the day. What A Week For AMC...
-
PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst
Wednesday, May 25, 2022 - 2:40pm | 682Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than its all-time high price ($174.79 vs. $66.50). While many issues have lost even more of...
-
Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks
Wednesday, March 9, 2022 - 1:03pm | 592Since the coronavirus pandemic began in early 2020, the FDA's plate has been full with reviews of COVID-19 vaccines and treatments. That has put the approval of many other drugs and therapies on the back burner. Hopefully the worst is behind us. David Nierengarten, Ph.D., a senior analyst...
-
PreMarket Prep Stock Of The Day: AT&T
Wednesday, January 26, 2022 - 4:38pm | 567“Guidance trumps earnings” is a commonly used phrase on Benzinga’s PreMarket Prep show. That is certainly the case with AT&T Inc. (NYSE: T) after its fourth-quarter report. The corresponding price action makes it the PreMarket Prep Stock Of The Day. AT&T Finds A...
-
Sean Udall Talks The 'January Effect' With PreMarket Prep Plus
Friday, December 31, 2021 - 4:26pm | 775Sean Udall joined PreMarket Prep Plus on Friday to talk about the "January Effect": the tendency for some stocks to rise in the first month of the year following a year-end sell-off for tax purposes. In his opinion, there has never been a greater year of tax-loss selling than what is...
-
Are These 2 Tech Stocks Trading At A Discount?
Friday, December 3, 2021 - 4:57pm | 538Friday’s PreMarket Prep Plus broadcast featured Sean Udall, the Tech Stock Strategist and publisher of The Udall Report. Sean is a unique type of investor that combines fundamental and technical analysis along with closely tracking investor sentiment. Udall was asked for two issues in...
-
'Wednesday's With Wedbush' On PreMarket Prep Plus: How Is The Retail Sector Looking?
Wednesday, December 1, 2021 - 2:11pm | 626On PreMarket Prep Plus "Wednesday’s With Wedbush," Senior Equity Research Analyst Tom Nikic covering the footwear and apparel sectors joined the broadcast. Overview: Nikic was asked to provide a macro overview of the retail sector coming out of a strong earnings...
-
PreMarket Prep Plus: Why Sean Udall Is Buying DraftKings, Apple
Friday, November 5, 2021 - 4:58pm | 496Even with the indexes at all-time highs, The Udall Report's publisher Sean Udall still has a few issues on his “buy” radar. The tech stock strategist shared the fundamental reasons for the two issues and detailed his game plan moving forward on Friday's PreMarket Plus...